Andrew Left is a famous short. If his report is bogus, NP and crew have to defend themselves with science. Seems like a bunch of name calling to me. He doesn't reference any sources, but when a stock gets frothy people sell first and ask questions later. Who wants to give up some of their fabulous gains? Real shareholders need to follow this story closely. It's going to be a battlefield. Still long. I believe in the science, but I certainly decreased my position. Citron and Andrew Left have taken on much more powerful companies than Cytodyn.